Natural lgM antibodies and inhibitors thereof

Details for Australian Patent Application No. 2012200909 (hide)

Owner President and Fellows of Harvard College Immune Disease Institute, Inc The Brigham and Women's Hospital, Inc

Inventors Carroll, Michael C.; Moore Jr., Francis D.; Hechtman, Herbert B

Agent Shelston IP

Pub. Number AU-A-2012200909

Parent 2005219839

Filing date 16 February 2012

Wipo publication date 8 March 2012

International Classifications

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

C07K 7/08 (2006.01) Peptides having 5 to 20 amino acids in a fully defined sequence

C07K 14/00 (2006.01) Peptides having more than 20 amino acids

C07K 16/00 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/18 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from animals or humans

C12N 15/12 (2006.01) Mutation or genetic engineering - Genes encoding animal proteins

Event Publications

1 March 2012 Complete Application Filed

8 March 2012 Application Open to Public Inspection

  Published as AU-A-2012200909

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2012200910-Information management apparatus and method, information management system, and non-transitory computer readable medium

2012200908-Method and device for treating a carbon dioxide-containing gas stream